Comprehensive Bleeding Disorders Center

Peoria, Illinois 61614

0 studies enrolling now · 4 studies all time

What they study most

Chronic Idiopathic Thrombocytopenic Purpura, Hemophilia A, Hemophilia A With Inhibitors, Purpura, Thrombocytopenic, Idiopathic

Studies at this site

• Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 — Completed
• Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A — Completed
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed
• International Immune Tolerance Study — Stopped early